Should family physicians routinely screen for hypercholesterolemia in children? Yes: The evidence supports universal screening

American Family Physician

Volumn 86, Issue 8, 2012, Pages 1-2

  Kavey, Rae Ellen W ^a   McBride, Patrick E ^b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; STATIN; TRIACYLGLYCEROL;

ABSENCE OF SIDE EFFECTS; APHERESIS; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; AUTOPSY; CHOLESTEROL BLOOD LEVEL; DYSLIPIDEMIA; EDITORIAL; FAMILIAL HYPERCHOLESTEROLEMIA; FAT INTAKE; HUMAN; HYPERCHOLESTEROLEMIA; INTIMA; NATIONAL HEALTH ORGANIZATION; OBESITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; TREATMENT OUTCOME; ADOLESCENT; AGE; CHILD; GENERAL PRACTICE; MASS SCREENING; METHODOLOGY;

ADOLESCENT; AGE FACTORS; ANTICHOLESTEREMIC AGENTS; CHILD; FAMILY PRACTICE; HUMANS; HYPERCHOLESTEROLEMIA; MASS SCREENING;

EID: 84868331426     PISSN: 0002838X     EISSN: 15320650     Source Type: Journal    
DOI: None     Document Type: Editorial

References (15)

1. Roger VL, et al. Executive summary: heart disease and stroke statistics-2012 update: a report from the American Heart Association [published correction appears in Circulation. 2012;125(22):e1001]. Circulation. 2012;125(1):188-197.
2. National Heart, Lung, and Blood Institute. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: summary report. Pediatrics. 2011;128(suppl 5): S213-S256.
3. National Heart, Lung, and Blood Institute. Integrated guidelines for cardiovascular health and risk reduction in children and adolescents. December 2011. http://www.nhlbi.nih.gov/guidelines/cvd_ped/index.htm. Accessed June 16, 2012.
4. Laitinen TT, et al. Ideal cardiovascular health in childhood and cardiometabolic outcomes in adulthood: The Cardiovascular Risk in Young Finns Study. Circulation. 2012;125(16):1971-1978.
5. Stamler J, et al. Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy. JAMA. 1999; 282(21):2012-2018.
6. Lewis C, et al. Can we make assumptions about the psychosocial impact of living as a carrier, based on studies assessing the effects of carrier testing? J Genet Couns. 2011;20(1):80-97.
7. Meulenkamp TM, et al. Predictive genetic testing for cardiovascular diseases: impact on carrier children. Am J Med Genet A. 2008;146A(24):3136-3146.
8. Smets EM, et al. Health-related quality of life of children with a positive carrier status for inherited cardiovascular diseases. Am J Med Genet A. 2008;146A(6):700-707.
9. American Academy of Pediatrics. National Cholesterol Education Program: report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics. 1992;89(3 pt 2):525-584.
10. Ritchie SK, et al. Universal versus targeted blood cholesterol screening among youth: the CARDIAC project. Pediatrics. 2010;126(2):260-265.
11. Mihaylova B, et al. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease. Lancet. 2102; 380(9841):581-590.
12. Raal FJ, et al. Reduction in mortality in subjects with homozygous familial hypercholesterolemia associated with advances in lipid-lowering therapy. Circulation. 2011;124(20):2202-2207.
13. Elis A, et al. Effect of lipid-lowering treatment on natural history of heterozygous familial hypercholesterolemia in past three decades. Am J Cardiol. 2011;108(2):223-226.
14. Ford ES, et al. Concentrations of low-density lipoprotein cholesterol and total cholesterol among children and adolescents in the United States. Circulation. 2009;119(8):1108-1115.
15. Marks D, et al. Cost effectiveness analysis of different approaches of screening for familial hypercholesterolaemia. BMJ. 2002;324(7349): 1303.